Developer of a unique therapeutic non-focused ultrasound system created for the treatment of resistant hypertension and high-blood pressure. The company has developed a therapeutic ultrasound system designed to decrease the over-activity of nerves leading to the kidneys. It designs and manufactures the Paradise System, a proprietary ultrasound ablation system for renal denervation. The System's intravascular catheters denervate renal nerves by combining the protection of water-based cooling of the renal artery with high intensity ultrasound energy for circumferential renal nerve ablation, enabling patients to decrease the over-activity of the sympathetic nervous system to lower blood pressure.
Clinical Trials - General
Privately Held (backing)